Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Combination with Metformin

被引：0
|
作者：
Andrea D. Fass
Jennifer A. Gershman
机构：
[1] Nova Southeastern University,Department of Pharmacy Practice
[2] College of Pharmacy,undefined
来源：
Advances in Therapy | 2013年 / 30卷
关键词：
Alogliptin; Combination therapy; Dipeptidyl peptidase-4 inhibitors; Linagliptin; Metformin; Saxagliptin; Sitagliptin; Type 2 diabetes; Vildagliptin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：337 / 353
页数：16
相关论文
共 50 条
  • [1] Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Combination with Metformin
    Fass, Andrea D.
    Gershman, Jennifer A.
    ADVANCES IN THERAPY, 2013, 30 (04) : 337 - 353
  • [2] Dipeptidyl peptidase-4 inhibitors and cardiovascular safety
    Davis, Timothy M. E.
    MEDICAL JOURNAL OF AUSTRALIA, 2014, 200 (08) : 450 - 451
  • [3] Fixed-Dose Combination of Dipeptidyl Peptidase-4 Inhibitors Plus Metformin in Patients with Type 2 Diabetes: A Review on Safety and Efficacy
    Alshahrani, Sultan M.
    Alshahrani, Hamed Ali
    Alshahrani, Saud Dhafer
    Alabdulla, Noura Mohammed
    Alshahrani, Yazeed Fahad
    Alshahrani, Abdulmohsen Nasser
    Alshahrani, Ali Mohammed
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (53A) : 53 - 59
  • [4] Systematic review and meta-analysis of efficacy and safety of combinational therapy with metformin and dipeptidyl peptidase-4 inhibitors
    Alanazi, Abdulrahman S.
    SAUDI PHARMACEUTICAL JOURNAL, 2015, 23 (06) : 603 - 613
  • [5] Dipeptidyl peptidase-4 inhibitors: pharmacokinetics, efficacy, tolerability and safety in renal impairment
    Davis, T. M. E.
    DIABETES OBESITY & METABOLISM, 2014, 16 (10): : 891 - 899
  • [6] Combination therapy of dipeptidyl peptidase-4 inhibitors and metformin in type 2 diabetes: rationale and evidence
    Liu, Y.
    Hong, T.
    DIABETES OBESITY & METABOLISM, 2014, 16 (02): : 111 - 117
  • [7] Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy
    Cox, Mary Elizabeth
    Rowell, Jennifer
    Corsino, Leonor
    Green, Jennifer B.
    DRUG HEALTHCARE AND PATIENT SAFETY, 2010, 2 : 7 - 19
  • [8] EFFICACY AND SAFETY OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS: SYSTEMATIC REVIEW AND META-ANALYSIS
    Perez, A.
    Franch, J.
    Fuster, E.
    Paz, S.
    Prades, M.
    Granell, M.
    VALUE IN HEALTH, 2014, 17 (07) : A335 - A336
  • [9] Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety
    Deacon, Carolyn F.
    Holst, Jens J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (15) : 2047 - 2058
  • [10] Cardiovascular safety of dipeptidyl peptidase-4 (DPP-4) inhibitors
    Gumprecht, Janusz
    CLINICAL DIABETOLOGY, 2015, 4 : 19 - 24
12345